Clinical Trials

Showing trials with last updates posted in 2025.

NCT04454489 | COMPLETED | PHASE2
21 participants

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2021-02-25
Completion:
2025-02-18
Conditions
  • Advanced Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Interventions
  • DRUG
  • RADIATION
NCT04452630 | TERMINATED
80 participants

Cardiovascular Consequences After COVID-19

Study Type:
OBSERVATIONAL
Last Updated:
2025-11-19
Start Date:
2020-06-23
Completion:
2023-02-01
Conditions
  • Cardiovascular Consequences After an Episode of COVID 19
Interventions
  • OTHER
No Results Yet
NCT04370509 | TERMINATED | PHASE2
6 participants

Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2021-02-09
Completion:
2025-02-28
Conditions
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Recurrent Clear Cell Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
  • Clear Cell Renal Cell Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page